Ultrack Systems Inc. (OTC: MJLB) Launches “PUR Rx” — A Scalable Digital Healthcare Platform Through Joint Venture with Synergy Health Rx Corp.

Rhea-AI Summary

Ultrack Systems (OTC: MJLB) has launched PUR Rx, a digital healthcare platform, through a 50/50 joint venture with Synergy Health Rx Corp. The platform aims to revolutionize prescription therapy access in Canada, where the digital health market is projected to reach CAD $4.7 billion by 2026 with 8.3% annual growth.

Ultrack will spearhead marketing and brand development, committing up to $10,000 quarterly in marketing spend through 2025. The venture combines Ultrack's digital expertise with Synergy Health's healthcare infrastructure, targeting 25-30% annual revenue growth over three years through recurring service fees, prescription margins, and third-party partnerships.

Positive

• Strategic 50/50 joint venture combining Ultrack's digital expertise with Synergy Health's healthcare infrastructure
• Targeting impressive 25-30% annual revenue growth over next three years
• Operating in growing Canadian digital health market projected to reach CAD $4.7B by 2026
• Built-in revenue streams through recurring service fees, prescription margins, and partnerships
• Lower customer acquisition costs due to Ultrack's digital marketing capabilities

Negative

• Limited initial marketing budget of only $10,000 per quarter through 2025
• Currently restricted to Ontario market with pending expansion to other provinces
• Faces competition from established players like WELL Health Technologies and Dialogue Health Technologies

CONCORD, Ontario, June 26, 2025 (GLOBE NEWSWIRE) -- Ultrack Systems Inc. (OTC: MJLB) is excited to announce the official launch of PUR Rx, a next-generation digital health platform formed through a 50/50 joint venture with Synergy Health Rx Corp. Designed to transform how Canadians access prescribed therapies, PUR Rx merges digital innovation with trusted medical infrastructure to deliver patient-first care at scale.

With the market for digital health in Canada expected to exceed CAD $4.7 billion by 2026 (Statista) and showing compound annual growth of 8.3%, PUR Rx arrives at a pivotal moment. The platform is poised to capture significant share in a sector driven by virtual care, streamlined prescriptions, and personalized healthcare delivery.

“PUR Rx is more than a joint venture—it’s a bold leap forward into the future of digital medicine,” said Reno Calabrigo, CEO of Ultrack Systems Inc. “This initiative perfectly blends our technology and branding strengths with Synergy Health’s healthcare credibility and regulatory footprint.”

Positioned at the Crossroads of Digital Health & Revenue Recurrence

PUR Rx leverages Ultrack’s proven capabilities in digital marketing, smart logistics, and user acquisition to accelerate platform growth and patient enrollment. Simultaneously, Synergy Health Rx contributes licensed infrastructure, prescription fulfillment, and a robust patient network, offering immediate operational scalability and regulatory compliance.

Key Platform Features:

• Virtual care access & real-time eligibility checks
• Prescription management through a licensed network
• Secure portals for patients and providers
• Data-driven marketing funnel to increase LTV (lifetime value) per user

Marketing-Driven Expansion with Ultrack at the Helm

Ultrack will lead the strategic rollout and brand development of PUR Rx through:

• Paid digital campaigns targeting specific therapeutic verticals
• SEO/SEM and geo-targeted outreach across Ontario
• B2C and B2B lead funnels for patient and clinic acquisition
• Investor-focused awareness campaigns and quarterly updates

Ultrack has committed to funding up to $10,000 per quarter in marketing spend through 2025, reflecting a lean but impactful customer acquisition strategy. This figure is expected to grow in 2026 as PUR Rx expands its footprint across Canada.

Competitive Advantage: Combining Agility with Compliance

While larger public digital health players like WELL Health Technologies and Dialogue Health Technologies have shown strong investor interest based on revenue growth and SaaS-style healthcare delivery models, PUR Rx differentiates itself through:

• Joint ownership of infrastructure and patient data
• Built-in fulfillment and regulatory compliance
• Lower CAC (customer acquisition cost) due to Ultrack's digital edge
• Agility to pivot into emerging markets or underserved communities

These advantages offer institutional upside and retail investor appeal, especially as digital-first healthcare becomes the new norm post-pandemic.

Financial Outlook: Recurring Revenue, Scalable Model

The PUR Rx venture is targeting 25%–30% annual revenue growth over the next three years, supported by recurring service fees, prescription margins, and third-party payer partnerships. As the platform gains traction, expansion into additional Canadian provinces and telehealth integrations will enable new revenue streams and possible white-label licensing opportunities.

About Ultrack Systems Inc.

Ultrack Systems Inc. (OTC: MJLB) is a technology and logistics innovator focused on digital marketing, smart infrastructure, and operational scale across healthcare, transportation, and enterprise verticals. The company enables growth through turnkey branding systems, digital outreach, and strategic partnerships.

About Synergy Health Rx Corp.

Synergy Health Rx Corp. is a licensed health services provider specializing in prescription management, patient education, and coordinated care delivery across Ontario. Known for its advocacy-first approach, the company brings operational excellence and compliance assurance to PUR Rx.

INVESTOR NOTE:
With healthcare increasingly shifting toward virtual care, tech-enabled prescribing, and personalized patient experiences, MJLB’s launch of PUR Rx marks a high-leverage entry into a multi-billion-dollar, high-retention industry. Investors seeking exposure to the future of healthcare delivery—and the platforms that power it—should be watching Ultrack Systems Inc. closely.

Safe Harbor Statement
This Press Release may contain certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The Company has tried, whenever possible, to identify these forward-looking statements using words such as "anticipates," "believes," "estimates," "expects," "plans," "intends," "potential" and similar expressions. These statements reflect the Company's current beliefs and are based upon information currently available to it. Accordingly, such forward-looking statements involve known and unknown risks, uncertainties and other factors which could cause the Company's actual results, performance or achievements to differ materially from those expressed in or implied by such statements. The Company undertakes no obligation to update or advise in the event of any change, addition or alteration to the information catered in this Press Release, including such forward-looking statements.

Investor Contact:
Email: info@ultrack.ca
Web: ultrack.ca, mybetterpets.com X: @UltrackI

FAQ

What is the joint venture structure between Ultrack Systems (MJLB) and Synergy Health Rx Corp?

The joint venture is a 50/50 partnership where Ultrack provides digital marketing and technology expertise while Synergy Health contributes licensed infrastructure and prescription fulfillment capabilities.

What is the projected market size for digital health in Canada by 2026?

The Canadian digital health market is expected to exceed CAD $4.7 billion by 2026, with a compound annual growth rate of 8.3%.

What are PUR Rx's revenue growth targets?

PUR Rx is targeting 25-30% annual revenue growth over the next three years, supported by recurring service fees, prescription margins, and third-party payer partnerships.

How much is Ultrack Systems (MJLB) investing in marketing for PUR Rx?

Ultrack has committed to investing up to $10,000 per quarter in marketing spend through 2025, with plans to increase spending in 2026 as the platform expands across Canada.

What are the key features of the PUR Rx platform?

PUR Rx offers virtual care access, real-time eligibility checks, prescription management through a licensed network, secure patient and provider portals, and data-driven marketing capabilities.